Home Cart 0 Sign in  
X

[ CAS No. 2973-77-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 2973-77-5
Chemical Structure| 2973-77-5
Chemical Structure| 2973-77-5
Structure of 2973-77-5 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 2973-77-5 ]

Related Doc. of [ 2973-77-5 ]

Alternatived Products of [ 2973-77-5 ]

Product Details of [ 2973-77-5 ]

CAS No. :2973-77-5 MDL No. :MFCD00016980
Formula : C7H4Br2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :SXRHGLQCOLNZPT-UHFFFAOYSA-N
M.W : 279.91 Pubchem ID :18100
Synonyms :

Calculated chemistry of [ 2973-77-5 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 49.25
TPSA : 37.3 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.95 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.75
Log Po/w (XLOGP3) : 2.9
Log Po/w (WLOGP) : 2.73
Log Po/w (MLOGP) : 2.28
Log Po/w (SILICOS-IT) : 2.86
Consensus Log Po/w : 2.5

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.74
Solubility : 0.0509 mg/ml ; 0.000182 mol/l
Class : Soluble
Log S (Ali) : -3.34
Solubility : 0.127 mg/ml ; 0.000453 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.47
Solubility : 0.0942 mg/ml ; 0.000337 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 1.0 alert
Leadlikeness : 0.0
Synthetic accessibility : 1.34

Safety of [ 2973-77-5 ]

Signal Word:Warning Class:
Precautionary Statements:P261-P305+P351+P338 UN#:
Hazard Statements:H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 2973-77-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 2973-77-5 ]
  • Downstream synthetic route of [ 2973-77-5 ]

[ 2973-77-5 ] Synthesis Path-Upstream   1~4

  • 1
  • [ 123-08-0 ]
  • [ 2973-77-5 ]
  • [ 2973-78-6 ]
Reference: [1] Green Chemistry, 2014, vol. 16, # 5, p. 2807 - 2814
[2] Tetrahedron Letters, 2005, vol. 46, # 51, p. 8959 - 8963
[3] Organic and Biomolecular Chemistry, 2012, vol. 10, # 35, p. 7120 - 7133
  • 2
  • [ 2973-77-5 ]
  • [ 74-88-4 ]
  • [ 108940-96-1 ]
YieldReaction ConditionsOperation in experiment
100% With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 15 h; Inert atmosphere 2,4-dibromo-3-methoxy-benzaldehyde (Compound 1) was dissolved in dry DMF, Add excess methyl iodide and potassium carbonate, stir under nitrogen at room temperature overnight, Extraction gave compound 2.
97% With potassium carbonate In N,N-dimethyl-formamide (2)
3,5-Dibromo-4-methoxybenzaldehyde
To a solution of 3,5-dibromo-4-hydroxybenzaldehyde (5.00 g, 17.9 mmol) in DMF (100 ml) were added potassium carbonate (3.22 g, 23.3 mmol) and iodomethane (1.45 ml, 23.3 mmol), and the mixture was stirred at room temperature for 10 hours.
The obtained mixture was poured into water and extracted with ethyl acetate.
The extracts were collected, washed with water and dried over magnesium sulfate anhydride, and the solvent was removed under reduced pressure to give the object compound as a solid. 5.10 g (yield: 97.0percent)
1H-NMR (CDCl3) δ; 3.97 (3H, s), 8.03 (2H, s), 9.80 (1H, s).
IR (KBr) cm-1; 1707, 1694, 1547, 1470, 1368, 1264, 1190, 987, 747, 731.
97% With potassium carbonate In N,N-dimethyl-formamide at 55℃; for 3 h; To a solution of 3,5-dibromo-4-hydroxybenzaldehyde (1.00 g, 3.57 mmol) and methyl iodide (MeI, 0.5 mL, 1.14 g, 8.03 mmol) in DMF (15 mL) was added anhydrous potassium carbonate (K2CO3, 0.992 g, 7.18 mmol). The reaction mixture was stirred at 55 °C for 3 h, cooled to room temperature, and quenched by addition of water (80 mL). The resultant white precipitate was filtered under vacuum, washed with water (40 mL), and dried to give the anisaldehyde intermediate (1.02 g, 3.47 mmol, 97percent) as a white solid: mp 90-91 °C; IR (NaCl) 1688 cm-1 (CO), 1546 cm-1 (CC); 1H NMR (300 MHz, CDCl3) δ 9.86 (s, 1H, CHO), 8.03 (s, 2H, ArH), 3.97 (s, 3H, OCH3); 13C NMR (75 MHz, CDCl3) δ 188.6 (CHO), 159.2 (C), 134.3 (C), 134.0 (CH), 119.3 (C), 60.8 (OCH3).
83% With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 18 h; 3,5-Dibromo-4-hydroxybenzaldehyde(1.40 g, 5.01 mmol), iodomethane (0.37 mL, 5.94 mmol), and K2CO3(845 mg, 6.11 mmol) were stirred in DMF (5.0 mL) at room temperature.After 18 h, the reaction was extracted into EtOAc (100 mL) and washed with H2O (2x25 mL) and brine (25 mL), dried over Na2SO4, filtered, and concentrated.Flash chromatographic purification over silica (9:1 hexanes:EtOAc) afforded3,5-dibromo-4-methoxybenzaldehydeas a white solid (1.22 g, 83percent).1H-NMR (500 MHz, CDCl3)d9.86 (s, 1H), 8.03 (s, 2H), 3.97 (s, 3H);13C-NMR (125 MHz, CDCl3)d188.43, 159.12, 134.20, 133.91, 119.31, 60.88; GC-MS 292m/z[MH]+, C8H6Br2O2requires 292; RP-HPLC: >99percent pure.
81% With potassium carbonate In N,N-dimethyl-formamide at 55℃; for 3 h; Potassium carbonate (100mg, 0.72mmol) was added to a solution of 3,5-dibromo-4-hydroxybenzaldehyde (100mg, 0.36mmol) and methyl iodide (51µL, 0.81mmol) in DMF (1.5mL). The mixture was stirred at 55 °C for 3h. After cooling to room temperature water (8mL) was added and the resulting precipitate was filtered and dried in vacuum to give 85mg (81percent) as a colorless solid. HPLC: Rt=7.04min. 1H-NMR (CDCl3, 500MHz): [ppm] = 9.86 (s, 1H), 8.03 (s, 2H), 3.97 (s, 3H). 13C-NMR (CDCl3, 125MHz): [ppm]= 188.5, 159.3, 134.4, 134.1, 119.5, 61.0.
3.62 g With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 24 h; Inert atmosphere Bromine (1.63 mL, 31.5 mmol) in acetic acid (5 mL) was added dropwise to a mixture of 4-hydroxybenzaldehyde (1.85 g,15 mmol) and sodium acetate (3.85 g, 46.5 mmol) in acid acetic (35 mL) at room temperature over 20 min. The reaction mixture was stirred for 1 h at room temperature. H2O (75 mL) was added and the solid was filtered, washed with H2O and dried under high vacuum to afford 3,5-dibromo-4-hydroxybenzaldehyde 14 as a white solid. To a stirred solution of 14 in DMF (50 mL) was added K2CO3 (4.15 g, 30 mmol) in portions, followed by the addition of MeI (3.9 mL, 60 mmol), and the mixture was stirred at room temperature for 24 h. The reaction mixture was taken in EtOAc (100 mL)and washed successively with H2O (50 mL), 1 M HCl (50 mL), saturated solution of NaHCO3 (50 mL), and brine (2 50 mL). The organic layer was dried with Na2SO4, filtered and concentrated under vacuum. The crude product was purified by chromatography on silica gel by using cyclohexane/EtOAc (90:10) as eluent to give3,5-dibromo-4-methoxybenzaldehyde 3c as a white solid in 82percent yield (3.62 g, 12.3 mmol).

Reference: [1] Tetrahedron Letters, 2011, vol. 52, # 2, p. 212 - 214
[2] Patent: CN104672104, 2017, B, . Location in patent: Paragraph 0059; 0065
[3] Patent: US2003/144338, 2003, A1,
[4] Tetrahedron, 2011, vol. 67, # 49, p. 9484 - 9490
[5] Journal of Chemical Research, 2015, vol. 39, # 6, p. 336 - 339
[6] Journal of Medicinal Chemistry, 2014, vol. 57, # 10, p. 4263 - 4272
[7] Tetrahedron Letters, 2010, vol. 51, # 37, p. 4812 - 4814
[8] Tetrahedron Letters, 1998, vol. 39, # 42, p. 7665 - 7668
[9] Journal of the American Chemical Society, 2010, vol. 132, # 4, p. 1359 - 1370
[10] Journal of Medicinal Chemistry, 2008, vol. 51, # 20, p. 6348 - 6358
[11] Bioorganic and Medicinal Chemistry Letters, 2017, vol. 27, # 15, p. 3441 - 3449
[12] Bioorganic and Medicinal Chemistry Letters, 2014, vol. 24, # 19, p. 4630 - 4637
[13] Chemistry - A European Journal, 2015, vol. 21, # 13, p. 4913 - 4917
[14] European Journal of Medicinal Chemistry, 2014, vol. 74, p. 541 - 551
[15] Bioorganic and Medicinal Chemistry, 2015, vol. 23, # 13, p. 3618 - 3628
  • 3
  • [ 2973-77-5 ]
  • [ 77-78-1 ]
  • [ 108940-96-1 ]
Reference: [1] Journal of the Chemical Society, Perkin Transactions 2: Physical Organic Chemistry (1972-1999), 1984, # 2, p. 231 - 238
  • 4
  • [ 2973-77-5 ]
  • [ 108940-96-1 ]
Reference: [1] Acta Chemica Scandinavica (1947-1973), 1973, vol. 27, p. 2574 - 2580
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 2973-77-5 ]

Aryls

Chemical Structure| 2973-78-6

[ 2973-78-6 ]

3-Bromo-4-hydroxybenzaldehyde

Similarity: 0.97

Chemical Structure| 20035-32-9

[ 20035-32-9 ]

4-Bromo-3-hydroxybenzaldehyde

Similarity: 0.91

Chemical Structure| 90-59-5

[ 90-59-5 ]

3,5-Dibromo-2-hydroxybenzaldehyde

Similarity: 0.89

Chemical Structure| 108940-96-1

[ 108940-96-1 ]

3,5-Dibromo-4-methoxybenzaldehyde

Similarity: 0.87

Chemical Structure| 1829-34-1

[ 1829-34-1 ]

3-Bromo-2-hydroxybenzaldehyde

Similarity: 0.86

Bromides

Chemical Structure| 2973-78-6

[ 2973-78-6 ]

3-Bromo-4-hydroxybenzaldehyde

Similarity: 0.97

Chemical Structure| 20035-32-9

[ 20035-32-9 ]

4-Bromo-3-hydroxybenzaldehyde

Similarity: 0.91

Chemical Structure| 90-59-5

[ 90-59-5 ]

3,5-Dibromo-2-hydroxybenzaldehyde

Similarity: 0.89

Chemical Structure| 108940-96-1

[ 108940-96-1 ]

3,5-Dibromo-4-methoxybenzaldehyde

Similarity: 0.87

Chemical Structure| 1829-34-1

[ 1829-34-1 ]

3-Bromo-2-hydroxybenzaldehyde

Similarity: 0.86

Aldehydes

Chemical Structure| 2973-78-6

[ 2973-78-6 ]

3-Bromo-4-hydroxybenzaldehyde

Similarity: 0.97

Chemical Structure| 20035-32-9

[ 20035-32-9 ]

4-Bromo-3-hydroxybenzaldehyde

Similarity: 0.91

Chemical Structure| 90-59-5

[ 90-59-5 ]

3,5-Dibromo-2-hydroxybenzaldehyde

Similarity: 0.89

Chemical Structure| 108940-96-1

[ 108940-96-1 ]

3,5-Dibromo-4-methoxybenzaldehyde

Similarity: 0.87

Chemical Structure| 1829-34-1

[ 1829-34-1 ]

3-Bromo-2-hydroxybenzaldehyde

Similarity: 0.86